Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma.
Russignan A, Spina C, Tamassia N, Cassaro A, Rigo A, Bagnato A, Rosanò L, Bonalumi A, Gottardi M, Zanatta L, Giacomazzi A, Scupoli MT, Tinelli M, Salvadori U, Mosna F, Zamò A, Cassatella MA, Vinante F, Tecchio C. Russignan A, et al. Br J Haematol. 2017 Sep;178(5):781-793. doi: 10.1111/bjh.14771. Epub 2017 Jun 9. Br J Haematol. 2017. PMID: 28597546 Free article.
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma.
Russignan A, Spina C, Tamassia N, Cassaro A, Rigo A, Bagnato A, Rosanò L, Bonalumi A, Gottardi M, Zanatta L, Giacomazzi A, Scupoli MT, Tinelli M, Salvadori U, Mosna F, Zamò A, Cassatella MA, Vinante F, Tecchio C. Russignan A, et al. Br J Haematol. 2019 Mar;184(6):1052-1055. doi: 10.1111/bjh.15240. Epub 2018 May 4. Br J Haematol. 2019. PMID: 29726006 Free article. No abstract available.
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma.
Russignan A, Dal Collo G, Bagnato A, Tamassia N, Bugatti M, Belleri M, Lorenzi L, Borsi E, Bazzoni R, Gottardi M, Terragna C, Vermi W, Giacomini A, Presta M, Cassatella MA, Krampera M, Tecchio C. Russignan A, et al. Front Oncol. 2021 Jan 8;10:600025. doi: 10.3389/fonc.2020.600025. eCollection 2020. Front Oncol. 2021. PMID: 33489901 Free PMC article.
Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study "Cervax".
Mohamed S, Lucchini E, Sirianni F, Porrazzo M, Ballotta L, Ballerini M, De Sabbata GM, De Bellis E, Cappuccio I, Granzotto M, Toffoletto B, Fortunati I, Russignan A, Florea EE, Torelli L, Zaja F. Mohamed S, et al. Among authors: russignan a. Front Oncol. 2023 Feb 27;13:1133348. doi: 10.3389/fonc.2023.1133348. eCollection 2023. Front Oncol. 2023. PMID: 36923438 Free PMC article.
Identification and characterization of the novel m.8305C>T MTTK and m.4440G>A MTTM gene mutations causing mitochondrial myopathies.
Scarpelli M, Carreño-Gago L, Russignan A, de Luna N, Carnicer-Cáceres C, Ariatti A, Verriello L, Devigili G, Tonin P, Garcia-Arumi E, Pinós T. Scarpelli M, et al. Among authors: russignan a. Neuromuscul Disord. 2018 Feb;28(2):137-143. doi: 10.1016/j.nmd.2017.10.006. Epub 2017 Oct 31. Neuromuscul Disord. 2018. PMID: 29174468
The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy.
Scarpelli M, Ricciardi GK, Beltramello A, Zocca I, Calabria F, Russignan A, Zappini F, Cotelli MS, Padovani A, Tomelleri G, Filosto M, Tonin P. Scarpelli M, et al. Among authors: russignan a. Neuroradiol J. 2013 Oct;26(5):520-30. doi: 10.1177/197140091302600505. Epub 2013 Nov 7. Neuroradiol J. 2013. PMID: 24199812 Free PMC article.
13 results